Study protocol to investigate the effect of a lifestyle intervention on body weight, psychological health status and risk factors associated with disease recurrence in women recovering from breast cancer treatment [ISRCTN08045231]

John M Saxton, Amanda Daley, Nicola Woodroofe, Robert Coleman, Hilary Powers, Nanette Mutrie, Vanessa Siddall, Helen Crank, John M Saxton, Amanda Daley, Nicola Woodroofe, Robert Coleman, Hilary Powers, Nanette Mutrie, Vanessa Siddall, Helen Crank

Abstract

Background: Breast cancer survivors often encounter physiological and psychological problems related to their diagnosis and treatment that can influence long-term prognosis. The aim of this research is to investigate the effects of a lifestyle intervention on body weight and psychological well-being in women recovering from breast cancer treatment, and to determine the relationship between changes in these variables and biomarkers associated with disease recurrence and survival.

Methods/design: Following ethical approval, a total of 100 patients will be randomly assigned to a lifestyle intervention (incorporating dietary energy restriction in conjunction with aerobic exercise training) or normal care control group. Patients randomised to the dietary and exercise intervention will be given individualised healthy eating dietary advice and written information and attend moderate intensity aerobic exercise sessions on three to five days per week for a period of 24 weeks. The aim of this strategy is to induce a steady weight loss of up to 0.5 Kg each week. In addition, the overall quality of the diet will be examined with a view to (i) reducing the dietary intake of fat to approximately 25% of the total calories, (ii) eating at least 5 portions of fruit and vegetables a day, (iii) increasing the intake of fibre and reducing refined carbohydrates, and (iv) taking moderate amounts of alcohol. Outcome measures will include body weight and body composition, psychological health status (stress and depression), cardiorespiratory fitness and quality of life. In addition, biomarkers associated with disease recurrence, including stress hormones, estrogen status, inflammatory markers and indices of innate and adaptive immune function will be monitored.

Discussion: This research will provide valuable information on the effectiveness of a practical, easily implemented lifestyle intervention for evoking positive effects on body weight and psychological well-being, two important factors that can influence long-term prognosis in breast cancer survivors. However, the added value of the study is that it will also evaluate the effects of the lifestyle intervention on a range of biomarkers associated with disease recurrence and survival. Considered together, the results should improve our understanding of the potential role that lifestyle-modifiable factors could play in saving or prolonging lives.

References

    1. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol. 1990;8:1327–1334.
    1. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20:1128–1134. doi: 10.1200/JCO.20.4.1128.
    1. Zumoff B, Gorzynski JG, Katz JL, Weiner H, Levin J, Holland J, et al. Nonobesity at the time of mastectomy is highly predictive of 10-year disease-free survival in women with breast cancer. Anticancer Res. 1982;2:59–62.
    1. Schapira DV, Kumar NB, Lyman GH, Cox CE. Obesity and body fat distribution and breast cancer prognosis. Cancer. 1991;67:523–528.
    1. Goodwin PJ, Boyd NF. Body size and breast cancer prognosis: A critical review of the evidence. Breast Cancer Res Treat. 1990;16:205–214. doi: 10.1007/BF01806329.
    1. Holmes MD, Kroenke CH. Beyond treatment: Lifestyle choices after breast cancer to enhance quality of life and survival. Womens Health Issues. 2004;14:11–13. doi: 10.1016/S1049-3867(03)00117-8.
    1. Gallagher J, Parle M, Cairns D. Appraisal and psychological distress six months after diagnosis of breast cancer. Br J Heath Psych. 2002;7:365–376. doi: 10.1348/135910702760213733.
    1. Epping-Jordan JE, Compas BE, Osowiecki DM, Oppedisano G, Gerhardt C, Primo K, et al. Psychological adjustment in breast cancer: processes of emotional distress. Health Psychol. 1999;18:315–326. doi: 10.1037/0278-6133.18.4.315.
    1. Maunsell E, Brisson J, Deschenes L. Psychological distress after initial treatment of breast cancer. Assessment of potential risk factors. Cancer. 1992;70:120–125.
    1. Golden-Kreutz DM, Andersen BL. Depressive symptoms after breast cancer surgery: relationships with global, cancer-related, and life event stress. Psycho-Oncology. 2004;13:211–220. doi: 10.1002/pon.736.
    1. Kissane DW, Grabsch B, Love A, Clarke DM, Bloch S, Smith GC. Psychiatric disorder in women with early stage and advanced breast cancer: a comparative analysis. Aust NZ J Psychiatry. 2004;38:320–326. doi: 10.1111/j.1440-1614.2004.01358.x.
    1. Kornblith AB, Ligibel J. Psychosocial and sexual functioning of survivors of breast cancer. Semin Oncol. 2003;30:799–813. doi: 10.1053/j.seminoncol.2003.08.025.
    1. McTiernan A, Rajan KB, Tworoger SS, Irwin M, Bernstein L, Baumgartner R, et al. Adiposity and sex hormones in postmenopausal breast cancer patients. J Clin Oncol. 2003;21:1961–1966. doi: 10.1200/JCO.2003.07.057.
    1. Bernstein L, Ross RK. Endogenous hormones and breast cancer. Epidemiol Rev. 1993;15:48–65.
    1. Thomas HV, Reeves GK, Key TJ. Endogenous estrogen and postmenopausal breast cancer: a quantitative review. Cancer Causes Control. 1997;8:922–928. doi: 10.1023/A:1018476631561.
    1. Hankinson SE, Willett WC, Manson JE, Colditz GA, Hunter DJ, Spiegelman D, et al. Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst. 1998;90:1292–1299. doi: 10.1093/jnci/90.17.1292.
    1. Calabrese JR, Kling MA, Gold PW. Alterations in immunocompetence during stress, bereavement, and depression: focus on neuroendocrine regulation. Am J Psychiatry. 1987;144:1123–1134.
    1. Andersen BL, Kiecolt-Glaser JK, Glaser R. A biobehavioral model of cancer stress and disease course. Am Psychol. 1994;49:389–404. doi: 10.1037/0003-066X.49.5.389.
    1. Bovbjerg DH. Psychoneuroimmunology. Implications for oncology? Cancer. 1991;67:828–832.
    1. Goodwin JS, Zhang DD, Ostir GV. Effect of depression on diagnosis, treatment, and survival of older women with breast cancer. J Am Geriatr Soc. 2004;52:106–111. doi: 10.1111/j.1532-5415.2004.52018.x.
    1. McEwen BS, Stellar E. Stress and the individual. Mechanisms leading to disease. Arch Intern Med. 1993;153:2093–2101. doi: 10.1001/archinte.153.18.2093.
    1. Madden KS, Felten DL. Experimental basis for neural-immune interactions. Physiol Rev. 1995;75:77–106.
    1. Banu N, Vaidya MP, Udupa KN. Alterations in circulating neurotransmitters & cortisol with severity of breast cancer. Indian J Med Res. 1988;87:479–53.
    1. Bryla CM. The relationship between stress and the development of breast cancer: a literature review. Oncol Nurs Forum. 1996;23:441–448.
    1. Kronfol Z, Nair M, Zhang Q, Hill EE, Brown MB. Circadian immune measures in healthy volunteers: relationship to hypothalamic-pituitary-adrenal axis hormones and sympathetic neurotransmitters. Psychosom Med. 1997;59:42–50.
    1. Benschop RJ, Nieuwenhuis EE, Tromp EA, Godaert GL, Ballieux RE, van Doornen LJ. Effects of beta-adrenergic blockade on immunologic and cardiovascular changes induced by mental stress. Circulation. 1994;89:762–769.
    1. Levy S, Herberman R. Prognostic risk assessment in primary breast cancer by behavioural and immunological parameters. Health Psychol. 1985;4:99–113. doi: 10.1037/0278-6133.4.2.99.
    1. Levy SM, Herberman RB, Lippman M, D'Angelo T, Lee J. Immunological and psychosocial predictors of disease recurrence in patients with early-stage breast cancer. Behav Med. 1991;17:67–75.
    1. Ehlert U, Patalla U, Kirschbaum C, Piedmont E, Hellhammer DH. Postpartum blues: salivary cortisol and psychological factors. J Psychosom Res. 1990;34:319–325. doi: 10.1016/0022-3999(90)90088-L.
    1. Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19:11–38. doi: 10.1016/0278-5846(94)00101-M.
    1. Schleifer SJ, Keller SE, Meyerson AT, Raskin MJ, Davis KL, Stein M. Lymphocyte function in major depressive disorder. Arch Gen Psychiatry. 1984;41:484–486.
    1. Caldwell CL, Irwin M, Lohr J. Reduced natural killer cell cytotoxicity in depression but not in schizophrenia. Biol Psychiatry. 1991;30:1131–1138. doi: 10.1016/0006-3223(91)90183-M.
    1. Maes M, Stevens W, Peeters D, DeClerck L, Scharpe S, Bridts C, et al. A study on the blunted natural killer cell activity in severely depressed patients. Life Sci. 1992;50:505–513. doi: 10.1016/0024-3205(92)90390-B.
    1. Nerozzi D, Santoni A, Bersani G, Magnani A, Bressan A, Pasini A, et al. Reduced natural killer cell activity in major depression: neuroendocrine implications. Psychoneuroendocrinology. 1989;14:295–301. doi: 10.1016/0306-4530(89)90031-0.
    1. Touitou Y, Levi F, Bogdan A, Benavides M, Bailleul F, Misset JL. Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors. J Cancer Res Clin Oncol. 1995;121:181–188. doi: 10.1007/BF01198101.
    1. Touitou Y, Bogdan A, Levi F, Benavides M, Auzeby A. Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens. Br J Cancer. 1996;74:1248–1252.
    1. van der Pompe G, Antoni MH, Heijnen CJ. Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology. 1996;21:361–374. doi: 10.1016/0306-4530(96)00009-1.
    1. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92:994–1000. doi: 10.1093/jnci/92.12.994.
    1. Abercrombie HC, Giese-Davis J, Sephton S, Epel ES, Turner-Cobb JM, Spiegel D. Flattened cortisol rhythms in metastatic breast cancer patients. Psychoneuroendocrinology. 2004;29:1082–1092. doi: 10.1016/j.psyneuen.2003.11.003.
    1. Bower JE, Ganz PA, Dickerson SS, Petersen L, Aziz N, Fahey JL. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology. 2005;30:92–100. doi: 10.1016/j.psyneuen.2004.06.003.
    1. Kaukua J, Pekkarinen T, Mustajoki P. Health-related quality of life in obese outpatients losing weight with very-low-energy diet and behavioural modification: a 2 year follow-up study. Int J Obes Relat Metab Disord. 2003;27:1233–1241. doi: 10.1038/sj.ijo.0802379.
    1. Jen KL, Djuric Z, DiLaura NM, Buison A, Redd JN, Maranci V, et al. Improvement of metabolism among obese breast cancer survivors in differing weight loss regimens. Obes Res. 2004;12:306–312.
    1. Djuric Z, DiLaura NM, Jenkins I, Darga L, Jen CK, Mood D, et al. Combining weight-loss counseling with the weight watchers plan for obese breast cancer survivors. Obes Res. 2002;10:657–665.
    1. Nieman DC, Nehlsen-Cannarella SL, Henson DA, Butterworth DE, Fagoaga OR, Warren BJ, Rainwater MK, et al. Immune response to obesity and moderate weight loss. Int J Obes Relat Metab Disord. 1996;20:353–360.
    1. Wu AH, Pike MC, Stram DO. Meta-analysis: Dietary fat intake, serum estrogen levels and the risk of breast cancer. J Natl Cancer Inst. 1999;91:529–534. doi: 10.1093/jnci/91.6.529.
    1. Pinto BM, Maruyama NC. Exercise in the rehabilitation of breast cancer survivors. Psycho-Oncology. 1999;8:191–206. doi: 10.1002/(SICI)1099-1611(199905/06)8:3<191::AID-PON355>;2-T.
    1. Nieman DC, Custer WF, Butterworth DE, Utter AC, Henson DA. Psychological response to exercise training and/or energy restriction in obese women. J Psychosom Res. 2000;48:23–29. doi: 10.1016/S0022-3999(99)00066-5.
    1. Friedenreich CM, Thune I, Brinton LA, Albanes D. Epidemiologic issues related to the association between physical activity and breast cancer. Cancer. 1998;83:600–610. doi: 10.1002/(SICI)1097-0142(19980801)83:3+<600::AID-CNCR2>;2-B.
    1. Gammon MD, John EM, Britton JA. Recreational and occupational physical activities and risk of breast cancer. J Natl Cancer Inst. 1998;90:100–117. doi: 10.1093/jnci/90.2.100.
    1. Mezzetti M, La Vecchia C, Decarli A, Boyle P, Talamini R, Franceschi S. Population attributable risk for breast cancer: diet, nutrition, and physical exercise. J Natl Cancer Inst. 1998;90:389–394. doi: 10.1093/jnci/90.5.389.
    1. Moradi T, Adami HO, Bergstrom R, Gridley G, Wolk A, Gerhardsson M, et al. Occupational physical activity and risk for breast cancer in a nationwide cohort study in Sweden. Cancer Causes Control. 1999;10:423–430. doi: 10.1023/A:1008922205665.
    1. Rockhill B, Willett WC, Hunter DJ, Manson JE, Hankinson SE, Colditz GA. A prospective study of recreational physical activity and breast cancer risk. Arch Intern Med. 1999;159:2290–2296. doi: 10.1001/archinte.159.19.2290.
    1. Verloop J, Rookus MA, van der KK, van Leeuwen FE. Physical activity and breast cancer risk in women aged 20–54 years. J Natl Cancer Inst. 2000;92:128–135. doi: 10.1093/jnci/92.2.128.
    1. Holmes MD, Chen WY, Feskanich D, Kroenke CH, Colditz GA. Physical activity and survival after breast cancer diagnosis. JAMA. 2005;293:2479–2486. doi: 10.1001/jama.293.20.2479.
    1. Cauley JA, Gutai JP, Kuller LH, LeDonne D, Powell JG. The epidemiology of serum sex hormones in postmenopausal women. Am J Epidemiol. 1989;129:1120–1131.
    1. Nelson ME, Meredith CN, Dawson-Hughes B, Evans WJ. Hormone and bone mineral status in endurance-trained and sedentary postmenopausal women. J Clin Endocrinol Metab. 1988;66:927–933.
    1. Geffken D, Cushman M, Burke G, Polak J, Sakkinen P, Tracy R. Association between physical actvity and markers of inflammation in a health elderly population. Am J Epidemiol. 2001;153:242–250. doi: 10.1093/aje/153.3.242.
    1. Kervinen H, Palosuo T, Manninen V, Tenkanen L, Vaarala O, Manttari M. Joint effects of C-reactive protein and other risk factors on acute coronary events. Am Heart J. 2001;141:580–585. doi: 10.1067/mhj.2001.113572.
    1. Smith JK, Dykes R, Douglas JE, Krishnaswamy G, Berk S. Long-term exercise and atherogenic activity of blood mononuclear cells in persons at risk of developing ischemic heart disease. JAMA. 1999;281:1722–1727. doi: 10.1001/jama.281.18.1722.
    1. Stauffer BL, Hoetzer GL, Smith DT, DeSouza CA. Plasma C-reactive protein is not elevated in physically active postmenopausal women taking hormone replacement therapy. J Appl Physiol. 2004;96:143–148. doi: 10.1152/japplphysiol.00360.2003.
    1. Bermudez EA, Rifai N, Buring J, Manson JE, Ridker PM. Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol. 2002;22:1668–1673. doi: 10.1161/01.ATV.0000029781.31325.66.
    1. Visser A, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282:2131–2135. doi: 10.1001/jama.282.22.2131.
    1. Rexrode KM, Pradhan A, Manson JE, Buring JE, Ridker PM. Relationship of total and abdominal obesity with CRP and IL-6 in women. Ann Epidemiol. 2003;13:674–682. doi: 10.1016/S1047-2797(03)00053-X.
    1. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and risk of incident colorectal cancer. JAMA. 2004;291:585–590. doi: 10.1001/jama.291.5.585.
    1. McMillan DC, Elahi MM, Sattar N, Angerson WJ, Johnstone J, McArdle CS. Measurement of the systemic inflammatory response predicts cancer-specific and non-cancer survival in patients with cancer. Nutr Cancer. 2001;41:64–69. doi: 10.1207/S15327914NC41-1&2_8.
    1. Dugue B, Leppanen EA, Teppo AM, Fyhrquist F, Grasbeck R. Effects of psychological stress on plasma interleukins-1 beta and 6, C-reactive protein, tumour necrosis factor alpha, anti-diuretic hormone and serum cortisol. Scand J Clin Lab Invest. 1993;53:555–561.
    1. Dentino AN, Pieper CF, Rao KMK, Currie MS, Harris T, Blazer DG, et al. Association of interleukin-6 and other biological variables with depression in older people. J Am Geriatr Soc. 1999;47:6–11.
    1. Maes M, Bosmans E, De jongh R, Kenis G, Vandoolaeghe E, Neels H. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine. 1995;9:853–858. doi: 10.1006/cyto.1997.0238.
    1. Lutgendorf SK, Garand L, Buckwalter KC, Reimer TT, Hong S, Lubaroff DM. Life stress, mood disturbance, and elevated interleukin-6 in healthy older women. J Gerontol A Biol Sci Med Sci. 1999;54:M434–9.
    1. Silvestri A, Gebara O, Vitale C, Wajngarten M, Leonardo F, Ramires JA, et al. Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response. Circulation. 2003;107:3165–3169. doi: 10.1161/01.CIR.0000074208.02226.5E.
    1. Baldwin MK, Courneya KS. Exercise and self-esteem in breast cancer survivors: An application of the exercise and self-esteem model. J Sport Exerc Psychol. 1997;19:347–359.
    1. Courneya KS, Friedenreich CM. Relationship between exercise during treatment and current quality of life among survivors of breast cancer. J Psychosoc Oncol. 1997;15:35–57.
    1. Campbell A, Mutrie N, White F, McGuire F, Kearney N. A pilot study of a supervised group exercise programme as a rehabilitation treatment for women with breast cancer receiving adjuvant treatment. Eur J Oncol Nurs. 2005;9:56–63. doi: 10.1016/j.ejon.2004.03.007.
    1. Cruess DG, Antoni MH, McGregor BA, Kilbourn KM, Boyers AE, Alferi SM, et al. Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosom Med. 2000;62:304–308.
    1. Davis H. Effects of biofeedback and cognitive therapy on stress in patients with breast cancer. Psychol Rep. 1986;59:967–974.
    1. Gruber BL, Hersh SP, Hall NR, Waletzky LR, Kunz JF, Carpenter JK, et al. Immunological responses of breast cancer patients to behavioral interventions. Biofeedback Self Regul. 1993;18:1–22. doi: 10.1007/BF00999510.
    1. van der Pompe G, Duivenvoorden HJ, Antoni MH, Visser A, Heijnen CJ. Effectiveness of a short-term group psychotherapy program on endocrine and immune function in breast cancer patients: an exploratory study. J Psychosom Res. 1997;42:453–466. doi: 10.1016/S0022-3999(96)00393-5.
    1. Peters C, Lotzerich H, Niemeier B, Schule K, Uhlenbruck G. Influence of a moderate exercise training on natural killer cytotoxicity and personality traits in cancer patients. Anticancer Res. 1994;14:1033–1036.
    1. Peters C, Lotzerich H, Niemer B, Schule K, Uhlenbruck G. Exercise, cancer and the immune response of monocytes. Anticancer Res. 1995;15:175–179.
    1. Nieman DC, Cook VD, Henson DA, Suttles J, Rejeski WJ, Ribisl PM, et al. Moderate exercise training and natural killer cell cytotoxic activity in breast cancer patients. Int J Sports Med. 1995;16:334–337.
    1. Fairey AS, Courneya KS, Field CJ, Bell GJ, Jones LW, Mackay JR. Randomized controlled trial of exercise and blood immune function in postmenopausal breast cancer survivors. J Appl Physiol. 2005;98:1534–1540. doi: 10.1152/japplphysiol.00566.2004.
    1. Nieman DC, Nehlsen-Cannarella SL, Markoff PA, Balk-Lamberton AJ, Yang H, Chritton DB, et al. The effects of moderate exercise training on natural killer cells and acute upper respiratory tract infections. Int J Sports Med. 1990;11:467–473.
    1. Nieman DC, Henson DA, Gusewitch G, Warren BJ, Dotson RC, Butterworth DE, et al. Physical activity and immune function in elderly women. Med Sci Sports Exerc. 1993;25:823–831.
    1. Nieman DC. Exercise and resistance to infection. Can J Physiol Pharmacol. 1998;76:573–580. doi: 10.1139/cjpp-76-5-573.
    1. Yamasaki S, Kan N, Harada T, Ichinose Y, Moriguchi Y, Li L, et al. Relationship between immunological parameters and survival of patients with liver metastases from breast cancer given immuno-chemotherapy. Breast Cancer Res Treat. 1993;26:55–65. doi: 10.1007/BF00682700.
    1. Wiltschke C, Krainer M, Budinsky AC, Berger A, Muller C, Zeillinger R, et al. Reduced mitogenic stimulation of peripheral blood mononuclear cells as a prognostic parameter for the course of breast cancer: a prospective longitudinal study. Br J Cancer. 1995;71:1292–1296.
    1. McTiernan A, Ulrich C, Kumai C, Bean D, Schwartz R, Mahloch J, et al. Anthropometric and hormone effects of an eight-week exercise-diet intervention in breast cancer patients: results of a pilot study. Cancer Epidemiol Biomarkers Prev. 1998;7:477–481.
    1. Utter AC, Nieman DC, Shannonhouse EM, Butterworth DE, Nieman CN. Influence of diet and/or exercise on body composition and cardiorespiratory fitness in obese women. Int J Sport Nutr. 1998;8:213–222.
    1. Treasure T, MacRae KD. Minimisation: the platinum standard for trials? Brit Med J. 1998;317:362–363.
    1. Wadden TA, Steen SN, Wingate BJ, Foster GD. Psychosocial consequences of weight reduction: how much weight loss is enough? Am J Clin Nutr. 1996;63:461S–465S.
    1. Daley AJ, Mutrie N, Crank H, Coleman R, Saxton J. Exercise therapy in women who have had breast cancer: design of the Sheffield women's exercise and well-being project. Health Educ Res. 2004;19:686–697. doi: 10.1093/her/cyg094.
    1. Prochaska JO, Norcross JC, Fowler J, Follick M, Abrams DB. Attendance and outcomes in a work-site weight control program: Processes and stages of change as process and predictor variables. Addictive Behav. 1992;17:35–45. doi: 10.1016/0306-4603(92)90051-V.
    1. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;2:92–98.
    1. Biddle SJH, Fox K, Boutcher SH, Faulkner G. The way forward for physical activity and the promotion of psychological well-being. In: Biddle SJH, Fox K, Boutcher SH, Faulkner G, editor. Physical Activity and Psychological Well-being. London: Routledge; 2000. pp. 154–168.
    1. Cohen S, Kamarck T, Mermelsstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:386–396.
    1. Beck AT, Steer R, Brown GK. Beck Depression Inventory (BDI-II) London: The Psychological Corporation; 1996.
    1. Ebbeling CB, Ward A, Puleo EM, Widrick J, Rippe JM. Development of a single-stage submaximal treadmill walking test. Med Sci Sports Exerc. 1991;23:966–973.
    1. Kolden GG, Strauman TJ, Ward A, Kuta J, Woods TE, Schneider KL, et al. A pilot study of group exercise training (GET) for women with primary breast cancer: feasibility and health benefits. Psycho-Oncology. 2002;11:447–456. doi: 10.1002/pon.591.
    1. Cella DF, Tulsky DS, Gray G, Serafin B, Linn E, Bonomi A, et al. The functional assessment of cancer therapy scale: Development and validation of the general measure. J Clin Oncol. 1993;11:570–579.
    1. Sallis JF, Haskell WL, Wood PD, Fortmann SP, Rogers T, Blair SN, et al. Physical activity assessment methodology in the Five-City Project. Am J Epidemiol. 1985;121:91–106.
    1. Chang L, Gusewitch GA, Chritton DB, Folz JC, Lebeck LK, Nehlsen-Cannarella SL. Rapid flow cytometric assay for the assessment of natural killer cell activity. J Immunol Methods. 1993;166:45–54. doi: 10.1016/0022-1759(93)90327-4.
    1. Mannering SI, Morris JS, Jensen KP, Purcell AW, Honeyman MC, van Endert PM, et al. A sensitive method for detecting proliferation of rare autoantigen-specific human T cells. J Immunol Methods. 2003;283:173–183. doi: 10.1016/j.jim.2003.09.004.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren